发明名称 |
ANLN PROTEIN AS AN ENDOCRINE TREATMENT PREDICTIVE FACTOR |
摘要 |
The present invention provides methods, uses and means for breast cancer prognostics and treatment prediction. Provided methods comprises the steps of: providing a sample earlier obtained from a breast cancer subject; evaluating the amount of ANLN protein present in at least part of said sample, and determining a sample value corresponding to said amount; comparing the sample value with a reference value; and, if said sample value is higher than said reference value, concluding that the subject is not likely to benefit from an endocrine treatment or that a prognosis for said subject is worse than a reference prognosis associated with the reference value.
|
申请公布号 |
CA2734174(A1) |
申请公布日期 |
2010.03.04 |
申请号 |
CA20092734174 |
申请日期 |
2009.09.01 |
申请人 |
ATLAS ANTIBODIES AB |
发明人 |
UHLEN, MATHIAS;PONTEN, FREDRIK;JIRSTROEM, KARIN |
分类号 |
G01N33/574;C07K14/47;C07K16/18 |
主分类号 |
G01N33/574 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|